scispace - formally typeset
T

Thomas M.S. Wolever

Researcher at University of Toronto

Publications -  398
Citations -  33938

Thomas M.S. Wolever is an academic researcher from University of Toronto. The author has contributed to research in topics: Glycemic index & Glycemic. The author has an hindex of 91, co-authored 388 publications receiving 31323 citations. Previous affiliations of Thomas M.S. Wolever include Toronto General Hospital & University of Agriculture, Faisalabad.

Papers
More filters
Journal ArticleDOI

Effect of antibiotics as cholesterol-lowering agents

TL;DR: It is concluded that antibiotics can reduce serum lipids acutely and may confound diagnostic measurements but indicate possible links between colonic microflora and blood lipids and the need to study ways of altering colonicmicroflora by nonantibiotic means as a potential therapeutic option.
Journal Article

Clinical experience with acarbose: results of a Canadian multicentre study.

TL;DR: The addition of acarbose expands the armamentarium available to clinicians for the optimization of glycemic control in patients with NIDDM and results in significant reductions in postprandial blood glucose levels.
Journal ArticleDOI

Reduction of Postprandial Glycemia by the Novel Viscous Polysaccharide PGX, in a Dose-Dependent Manner, Independent of Food Form

TL;DR: Addition of NVP to different food matrices is highly effective in lowering the glycemic index of a food in a dose-responsive manner.
Journal ArticleDOI

Psyllium reduces blood lipids in men and women with hyperlipidemia.

TL;DR: It is concluded that 6.7 g of psyllium fiber daily, with a low-fat diet, reduces serum cholesterol levels in both men and women with hyperlipidemia.
Journal ArticleDOI

One-year Acarbose Treatment Raises Fasting Serum Acetate in Diabetic Patients

TL;DR: It is concluded, in subjects with diabetes who tolerate therapy for a 1‐year period, that acarbose treatment increases serum acetate, and the magnitude of change in acetate was unrelated to side‐effects or changes in blood glucose control or serum lipids.